Based on the findings of these studies, Falini et al. proposed that NPM1-mut MDS represent NPM1-mut AML diagnosed at an early stage and that must be treated with intensive chemotherapy, followed by allogeneic SCT, as typical NPM1-mut AMLs [74]. The gene discussed is NPM1; the disease is myelodysplastic syndrome.